Free · Substack Oct 13, 2026 · 1 min read

Afternoon update

Johnson & Johnson ($JNJ) is down 5.65% this afternoon at $248.82 after falling as much as 7.03% intraday, as weak MedTech growth outweighed a…

Afternoon update
Intraday Movers · Afternoon · Intraday Movers — October 13 AFTERNOON · Tue, Oct 13

Johnson & Johnson ($JNJ) is down 5.65% this afternoon at $248.82 after falling as much as 7.03% intraday, as weak MedTech growth outweighed a third-quarter beat and a guidance raise.

  • Johnson & Johnson posted Q3 revenue of $25.4B and adjusted EPS of $2.59, above the $2.52 estimate, and raised 2026 guidance to $101.0B–$101.4B in sales and $11.05–$11.15 in adjusted EPS. MedTech sales rose only 2.5% to $8.6B. Shares opened 3.48% lower and hit $245.19 before a modest recovery; market cap is $599.63B.
  • Meta Platforms is up 2.85% at $764.10, rising for a second day after the rollout of its Muse Wonder AI model. It dipped 1.09% early, then climbed as much as 3.81% as Truist raised its price target to $1,000 from $763.
  • Healthcare is the weakest sector today at -1.28%. Energy leads at +1.67%, followed by communication services at +1.18%. Technology is down 0.26%, with memory and chip names under pressure after news of an apparent breakthrough from a Chinese chipmaker.

Overall, these are intraday readings, not closing returns; risk appetite is uneven this afternoon. J&J's slide weighs on healthcare, while Meta's AI catalyst helps lift communication services even as technology stays soft.

Originally published on the Position Tracker Substack. Read on Substack ↗

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →